- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01449097
Adductor-Canal-Blockade Versus the Femoral Nerve Block Effect on Muscle Strength and Mobilization in Healthy Volunteers
December 21, 2011 updated by: Pia Jaeger, Rigshospitalet, Denmark
Comparison of the Efficacy of the Adductor-Canal-Blockade Versus the Femoral Nerve Block on Muscle Strength and Mobilization in Healthy Volunteers: a Randomized Study
The aim of this study is to investigate the efficacy of the Adductor-Canal-Blockade versus the femoral nerve block versus placebo on muscle strength in healthy volunteers.
The investigators hypothesize that the Adductor-Canal-Blockade results in a lesser reduction of the quadriceps muscle strength compared to the femoral nerve block.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- written informed consent
- ASA 1
- BMI > 18 og < 25
Exclusion Criteria:
- Can not cooperate to the exam
- Do not speak or understand Danish
- Drug allergy
- Alcohol or drug abuse
- Daily consumption of analgetics on prescription
- Any drug intake within the last 48 hours
- Neuromuscular defects in the femoral nere, the obturator nerve or the muscles of the thigh.
- Previous surgery or trauma to the lower limb
- Diabetes Mellitus
- Intake of steroids, except steroids for inhalation
- Physical exercise within the last 24 hours prior to Day 1 and 2 of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
|
US-guided Adductor-Canal-Blockade/femoral nerve block with saline
|
Experimental: Adductor-Canal-Blockade
|
US-guided Adductor-Canal-blockade with Ropivacaine
|
Active Comparator: The femoral nerve block
|
US-guided femoral nerve block with ropivacaine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the difference in quadriceps muscle strength between the Adductor-Canal-Blockade and placebo
Time Frame: 0-6 hours
|
0-6 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The difference in quadriceps muscle strength between the Adductor-Canal-Blockade and the femoral nerve block
Time Frame: 0-6 hours
|
0-6 hours
|
The difference in quadriceps muscle strength between the placebo and the femoral nerve block
Time Frame: 0-6 hours
|
0-6 hours
|
The difference in adductor muscle strength between the groups
Time Frame: 0-6 hours
|
0-6 hours
|
The difference in mobilization between the groups
Time Frame: 0-6 hours
|
0-6 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
October 6, 2011
First Submitted That Met QC Criteria
October 6, 2011
First Posted (Estimate)
October 7, 2011
Study Record Updates
Last Update Posted (Estimate)
December 22, 2011
Last Update Submitted That Met QC Criteria
December 21, 2011
Last Verified
December 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- SM2-PJ-11
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PMV Pharmaceuticals, IncRecruitingHealthy VolunteersUnited States
Clinical Trials on Adductor-Canal-Blockade
-
University Medical Centre LjubljanaNot yet recruitingKnee OsteoarthritisSlovenia
-
Rigshospitalet, DenmarkCompleted
-
Benaroya Research InstituteCompletedPost-Operative PainUnited States
-
Rigshospitalet, DenmarkCompletedTotal Knee ArthroplastyDenmark
-
Hospital for Special Surgery, New YorkRecruiting
-
Diskapi Teaching and Research HospitalRecruitingKnee Replacement Arthroplasty | Nerve Block | Pain MeasurementTurkey
-
Rigshospitalet, DenmarkCompletedPostoperative Pain | Knee ArthroplastyDenmark
-
Rigshospitalet, DenmarkCompletedPostoperative Pain | Knee ArthroplastyDenmark
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
Lawson Health Research InstituteCompleted